Pediatric Safety Evaluation of An AS-Adjuvanted H5N1 Prepandemic Candidate Vaccine in Children Aged 3–9 Years: A Phase II Study

✍ Scribed by A. Ballester; M. Garcés-Sánchez; M.V. Planelles Cantarino; M. Dramé; N. Bouveret; P. Gillard; J. Díez-Domingo

• Book ID: 118449875
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 54 KB
• Volume: 12
• Category: Article
• ISSN: 1201-9712
• DOI: 10.1016/j.ijid.2008.05.364